Dr. José Baselga, chief medical officer at Sloan Kettering Cancer Center in New York. didn't follow financial disclosure rules set by the American Association for Cancer Research when he was its president. nyti.ms/2MUXlcl
When you’re asked to donate to cancer research at a leading hospital, you’re basically giving money to wealthy doctors on the pharmaceutical industry payroll. Given all the potential + actual self-dealing, how do these places keep their nonprofit + charity status? ~ Gwen, Queens
"One of the most vulnerable states of being is a person walking into a cancer treatment center. How do they know what they are in for when a trial drug treatment is offered to them? They don't. In my opinion there should be no financial relationship between drug producers... 1/
"...and drug prescribers, especially when the side effects of trial oncology drugs can be so devastating. How can a patient be sure their best interest are being looked after if there is a monetary incentive in helping to see that these drugs come to market?" ~ JCafe, Brooklyn
"The wall between academic research and for-profit companies was intentionally breached by the Bayh-Dole Act under Reagan, as part of the general ideology that giving people a financial motive will make for more innovation rather than just being conflict of interest. 1/
"Advances in cancer have been relatively few, and disprove that libertarian hypothesis." ~ priceofcivilization, Houston 2/x
IMO cancer has become too profitable a business to end by finding its root causes and cures too soon. Its victims and their families deserve better.
IMO cancer has become too profitable a business to end by finding its root causes and cures too soon. Its victims and their families deserve better.
